Overexpression of FTO effectively suppressed the IGF2BP3-induced upregulation of MIB1 and overall increase in m6A (Fig. 5n, o), inhibiting IGF2BP3-induced NETosis and glioma cell survival (Fig. 5p–r). The gene discussed is IGF2BP3; the disease is central nervous system cancer.